Artificial intelligence in digital genome is being adopted widely owing to its ability to analyze genome sequences with precision and accuracy. Artificial intelligence-powered genome sequencing helps identify disease-associated genetic variations and enables early detection of life-threatening diseases such as cancer. It assists in drug discovery and developing personalized treatments.
The global Artificial Intelligence in Digital Genome Market is estimated to be valued at US$ 565.69 Mn in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Adoption of artificial intelligence is accelerating the growth of the artificial intelligence in digital genome market. AI helps analyze genome data faster and more accurately as compared to traditional methods. It identifies complex patterns and hidden insights in genome data, which would have otherwise taken much longer through manual analysis. Moreover, AI assists in clinical decision support, drug discovery, precision medicine, and population health management. Advancements in AI algorithms coupled with availability of huge amounts of genomic data is fueling the artificial intelligence adoption in the digital genome market.
Segment Analysis
The Global Artificial Intelligence In Digital Genome Market Scope is segmented on the basis of offering, technology, application, end user, and geography. Based on offering, the hardware segment dominated the market in 2021 with highest market share owing to growth in demand for high-performance computing systems for processing large genomic datasets.
Key Takeaways
The global artificial intelligence in digital genome market is expected to witness high growth over the forecast period 2023 to 2030. The global Artificial Intelligence in Digital Genome Market is estimated to be valued at US$ 565.69 Mn in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period 2023 to 2030.
Regional analysis: North America accounted for the largest share of the global market in 2021. This is attributed to the presence of major players in countries like the US and Canada. Asia Pacific is expected to witness the highest CAGR during the forecast period owing to increasing initiatives by governments focused on precision medicine and genomics research.
Key players analysis: Key players operating in the artificial intelligence in digital genome market are Intel Corporation, IBM Corporation, Microsoft Corporation, NVIDIA Corporation, Deep Genomics, Fabric Genomics, Anthropic, BenevolentAI, and Verge Genomics. Intel Corporation stands as the dominant player owing to its varied portfolio of hardware and software solutions for genomics.
Get more insights on this topic: https://www.trendingwebwire.com/artificial-intelligence-in-digital-genome-market-size-and-share-analysis-growth-trends-and-forecasts/
Explore more information on this topic, Please visit: https://filmik.in/design-brilliance-unleashed-elevate-brands-with-the-expert-packaging-design-services/
